The BalancedInvestor Club

Drug Manufacturers General Industry Analysis

22 companies analyzed • Returns from -111.7% to +97.1% • Data through May 1, 2026

Company List (22 Results)

View:
Sort:

Industry Performance

(22/22 companies)
2025-05-05 → 2026-05-01
Weighted Avg
+20.1%
Best
+97.1%
Worst
-111.7%
Returns Distribution
Top 5
1. SCLXW+97.1%2. AZN+94.2%3. SCLX+66.7%4. BIIB+42.9%5. OGN+42.2%
Bottom 5
1. NSRX-111.7%2. NVO-45.5%3. MDCXW-41.8%4. SNY-15.9%5. MIRA-11.8%

SCLXW

+97.1%

Scilex Holding Company

AZN

+94.2%

AstraZeneca PLC ADR

SCLX

+66.7%

Scilex Holding Company

BIIB

+42.9%

Biogen Inc

OGN

+42.2%

Organon & Co

JNJ

+38.2%

Johnson & Johnson

MRK

+30.3%

Merck & Company Inc

GSK

+28.4%

GlaxoSmithKline PLC ADR

AMRN

+28.3%

Amarin Corporation PLC

NVS

+25.9%

Novartis AG ADR

GILD

+24.7%

Gilead Sciences Inc

AMGN

+16.4%

Amgen Inc

LLY

+16.0%

Eli Lilly and Company

BMY

+15.1%

Bristol-Myers Squibb Company

GRFS

+10.0%

Grifols SA ADR

PFE

+9.8%

Pfizer Inc

ABBV

+5.2%

AbbVie Inc

MIRA

-11.8%

MIRA Pharmaceuticals, Inc. Common Stock

SNY

-15.9%

Sanofi ADR

MDCXW

-41.8%

Medicus Pharma Ltd. Warrant

1–20 of 22
Page 1 of 2
Methodology

The Weighted Average return (+20.1%) is calculated using market capitalization as weights. This gives larger companies more influence on the average, providing a more market-representative view.

19 companies with market cap data included: AZN, SCLX, BIIB, OGN, JNJ, MRK, GSK, AMRN, NVS, GILD and 9 more...

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer